Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Pressure is building on BP chief exec Murray Auchincloss (pictured) following reports that Elliott was disappointed with his new strategy.

European shares were mostly lower on Thursday, after the White House threatened to place a 2005 tariff on EU wine, champagne and spirits in response to the bloc's own retaliatory measures.

AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. | ...

Body mass index (BMI) was almost three times more likely to classify children as overweight than waist circumference-to-height ratio, according to a new study.

Company Details Strategic Growth Initiatives to Expand Market Presence Across Asia and the Middle EastKUALA LUMPUR, Malaysia, March 13, 202 ...

DMEGC released its 2024 annual report which reveals that the company achieved annual revenue of ?2.4 billion, with a net profit attributable to the parent company of ?238 million, marking a slight ...

VCI Global (VCIG) announced an update on its strategic expansion plan and vision for market dominance across Asia and the Middle East. The ...

Leadership coach Eric Gilbert, who specializes in helping professionals battling anxiety, recently announced that his company, Rising Calm Center, is launching a new and highly effective program, ...

Cooler February inflation doesn’t mean Fed will lower rates, promising obesity drug could challenge Novo Nordisk and Eli ...

Vicarious Surgical (NYSE:RBOT) announced today that it named Sarah Romano as its next chief financial officer (CFO).

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.